Afsheen N. Iqbal
- Oncology top 10%
- Lung Cancer Research Studies 5
- Colorectal Cancer Treatments and Studies 3
- Cancer Immunotherapy and Biomarkers 2
- Developmental Neuroscience top 10%
-
- Lung Cancer Treatments and Mutations 9
-
- Cardiac and Coronary Surgery Techniques 3
- Colorectal and Anal Carcinomas 2
-
- Cardiac, Anesthesia and Surgical Outcomes 3
-
- Radiopharmaceutical Chemistry and Applications 2
- Co-authors
- Gregory J. RielyMark G. KrisHelena A. YuKathryn C. ArbourMatthew D. HellmannShirish M. GadgeelHira RizviAdam J. Schoenfeld
- Partner nations
- United StatesPakistanUnited Kingdom
In The Last Decade
Afsheen N. Iqbal
21 papers receiving 571 citations
Hit Papers
Peers
Comparison fields: 5 of 56
- Oncology 341
- Developmental Neuroscience 49
- Pulmonary and Respiratory Medicine 327
- Cancer Research 75
- Emergency Medicine 47
Countries citing papers authored by Afsheen N. Iqbal
This map shows the geographic impact of Afsheen N. Iqbal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Afsheen N. Iqbal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Afsheen N. Iqbal more than expected).
Fields of papers citing papers by Afsheen N. Iqbal
This network shows the impact of papers produced by Afsheen N. Iqbal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Afsheen N. Iqbal. The network helps show where Afsheen N. Iqbal may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Afsheen N. Iqbal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 1 | |
| 4 | 2023 | 23 | |
| 5 | 2023 | 0 | |
| 6 | Role of neutrophil lymphocyte ratio (NLR) in predicting disease severity in covid -19: A multicenter retrospective study | 2021 | 0 |
| 7 | 2021 | 10 | |
| 8 | 2020 | 10 | |
| 9 | Severe immune-related adverse events are common with sequential PD-(L)1 blockade and osimertinibbreakdown → | 2019 | 271 |
| 10 | 2018 | 1 | |
| 11 | Skeletonization of Left Internal Mammary Artery in Coronary Artery Bypass Grafting. | 2016 | 3 |
| 12 | 2016 | 0 | |
| 13 | 2016 | 105 | |
| 14 | Induced remote ischemic pre-conditioning on ischemia-reperfusion injury in patients undergoing coronary artery bypass. | 2010 | 62 |
| 15 | Coronary endarterectomy for severe diffuse coronary artery disease. | 2009 | 2 |
| 16 | 2008 | 6 | |
| 17 | 2008 | 2 | |
| 18 | 2004 | 3 | |
| 19 | 2000 | 15 | |
| 20 | 1995 | 5 |
About Afsheen N. Iqbal
Afsheen N. Iqbal is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Developmental Neuroscience, having authored 26 papers that have together received 578 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (9 papers), Lung Cancer Research Studies (5 papers), Colorectal Cancer Treatments and Studies (3 papers), Cardiac and Coronary Surgery Techniques (3 papers), Cardiac, Anesthesia and Surgical Outcomes (3 papers), Radiopharmaceutical Chemistry and Applications (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Colorectal and Anal Carcinomas (2 papers). The work is most often cited by research in Oncology (341 citations), Developmental Neuroscience (49 citations) and Pulmonary and Respiratory Medicine (327 citations). Afsheen N. Iqbal has collaborated with scholars based in United States, Pakistan and United Kingdom. Frequent co-authors include Gregory J. Riely, Mark G. Kris, Helena A. Yu, Kathryn C. Arbour, Matthew D. Hellmann, Shirish M. Gadgeel, Hira Rizvi, Adam J. Schoenfeld, Jeffrey Girshman and Nasir Ali. Their work appears in journals such as Journal of Clinical Oncology, Blood and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.